The Impact of Heavy Smoking on Anastomotic Leakage and Stricture After Low Anterior Resection in Rectal Cancer Patients
- 316 Downloads
Anastomotic complications after low anterior resection are associated with perianastomotic ischemia. Smoking is one of the main causes of microvascular disease that is correlated with tissue ischemia. The purpose of the present study was to assess the impact of smoking on anastomotic complications after low anterior resection in rectal cancer patients.
Between January 2005 and December 2008, 412 patients underwent low anterior resection for rectal cancers by a single surgeon at Seoul National University Hospital. Excluded from this series were 197 patients with postoperative radiation therapy, cancers that were located above 10 cm from the anal verge, or lack of medical records, and the remaining 215 patients were included for analysis. Significant variables in the univariate analysis were subsequently subject to multivariate analysis for identification of risk factors for complications.
The rate of anastomotic complications was 10.7% (23 of 215 patients). Univariate analysis showed that male gender, body mass index higher than 25 kg/m2, smoking history, smoking amount, type of operation, and presence of a protective stoma were associated with anastomotic complications. In multivariate analysis, a history of heavy smoking was a significant risk factor for anastomotic complications.
A history of heavy smoking (more than 40 pack-years) is an independently significant risk factor for anastomotic complications after low anterior resection in rectal cancer patients.
Conflict of interest
The authors declare no conflict of interest or financial tie to disclose.
- 3.Iancu C, Mocan LC, Todea-Iancu D et al (2008) Host-related predictive factors for anastomotic leakage following large bowel resections for colorectal cancer. J Gastrointest Liver Dis 17:299–303Google Scholar
- 24.Racke K, Schworer H, Simson G (1992) Effects of cigarette smoking or ingestion of nicotine on platelet 5-hydroxytryptamine (5-HT) levels in smokers and non-smokers. Clin Invest 70:201–204Google Scholar